Literature DB >> 23264348

Reducing radiation dose at CT colonography: decreasing tube voltage to 100 kVp.

Kevin J Chang1, Dominique B Caovan, David J Grand, Walter Huda, William W Mayo-Smith.   

Abstract

PURPOSE: To assess the effect of a decrease in tube voltage from 120 kVp to 100 kVp on dose, contrast-to-noise ratio (CNR), and three-dimensional (3D) image quality in patients undergoing computed tomographic (CT) colonography as well as to determine how these changes are affected by patient size.
MATERIALS AND METHODS: This HIPAA-compliant and institutional review board-approved retrospective study included 63 consecutive patients who underwent CT colonography and who waived informed consent. Scanning was performed with patients in the supine (120 kVp) and prone (100 kVp) positions, with other parameters unchanged. Volume CT dose index (CTDI(vol)), dose-length product (DLP), image noise, attenuation of selected materials, and CNR were compared with the Wilcoxon matched-pairs signed rank test. Two readers blinded to tube voltage independently assessed 3D endoluminal image quality. The k coefficients were calculated for interobserver agreement. Average image quality ratings were compared with the Wilcoxon signed rank test. All recorded data were stratified by patient anteroposterior diameter to determine effects of patient size.
RESULTS: Decreasing tube voltage from 120 to 100 kVp resulted in a 20% decrease in CTDI(vol) (P < .001) and a 16% decrease in DLP (P < .001). Image noise increased by 32% (P < .001). Mean attenuation of tagged fluid increased from 395 to 487 HU (P < .001). There was no change in mean CNR of tagged fluid (17.1 at 120 kVp, 16.8 at 100 kVp; P = .37), regardless of patient size. The 3D image quality decreased slightly from a median score of 5 out of 5 to 4 out of 5 (P < .001). There was substantial interobserver agreement.
CONCLUSION: A decrease in tube voltage from 120 to 100 kVp results in a significant decrease in radiation dose but only a minimal decrease in 3D image quality at all patient sizes. © RSNA, 2012.

Entities:  

Mesh:

Year:  2012        PMID: 23264348     DOI: 10.1148/radiol.12120134

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  5 in total

1.  Sub-milliSievert (sub-mSv) CT colonography: a prospective comparison of image quality and polyp conspicuity at reduced-dose versus standard-dose imaging.

Authors:  Meghan G Lubner; B Dustin Pooler; Douglas R Kitchin; Jie Tang; Ke Li; David H Kim; Alejandro Munoz del Rio; Guang-Hong Chen; Perry J Pickhardt
Journal:  Eur Radiol       Date:  2015-04-23       Impact factor: 5.315

2.  Model-based vs hybrid iterative reconstruction technique in ultralow-dose submillisievert CT colonography.

Authors:  L Lambert; P Ourednicek; J Jahoda; A Lambertova; J Danes
Journal:  Br J Radiol       Date:  2015-01-21       Impact factor: 3.039

3.  Optimizing CT technique to reduce radiation dose: effect of changes in kVp, iterative reconstruction, and noise index on dose and noise in a human cadaver.

Authors:  Kevin J Chang; Scott Collins; Baojun Li; William W Mayo-Smith
Journal:  Radiol Phys Technol       Date:  2016-10-03

4.  Clinical indications for computed tomographic colonography: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastrointestinal and Abdominal Radiology (ESGAR) Guideline.

Authors:  Cristiano Spada; Jaap Stoker; Onofre Alarcon; Federico Barbaro; Davide Bellini; Michael Bretthauer; Margriet C De Haan; Jean-Marc Dumonceau; Monika Ferlitsch; Steve Halligan; Emma Helbren; Mikael Hellstrom; Ernst J Kuipers; Philippe Lefere; Thomas Mang; Emanuele Neri; Lucio Petruzziello; Andrew Plumb; Daniele Regge; Stuart A Taylor; Cesare Hassan; Andrea Laghi
Journal:  Eur Radiol       Date:  2015-02       Impact factor: 5.315

5.  Pilot study on image quality and radiation dose of CT colonography with adaptive iterative dose reduction three-dimensional.

Authors:  Hesong Shen; Dan Liang; Mingyue Luo; Chaijie Duan; Wenli Cai; Shanshan Zhu; Jianping Qiu; Wenru Li
Journal:  PLoS One       Date:  2015-01-30       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.